How Online Psychiatrists Coordinate Addiction Care With Primary Physicians

How Online Psychiatrists Coordinate Addiction Care With Primary Physicians

An abstract image of different specialties talking to one another.

Why coordination matters in addiction treatment shared with primary care

Addiction care rarely sits with one clinician. A patient stabilizing on buprenorphine or naltrexone typically also needs liver and renal labs, pregnancy or infectious disease screening, and management of diabetes, hypertension, or pain — work that stays with the primary physician while the psychiatric prescriber handles induction, dose adjustments, and relapse risk. SAMHSA describes medications for opioid use disorder as evidence-based treatment and publishes integration guidance written specifically for physicians, which assumes two clinicians are actually talking to each other.

Telepsychiatry solves the staffing half of the problem: it puts a prescriber in front of patients in counties with no local psychiatric coverage. The Health Resources and Services Administration’s best-practice guidance notes that telehealth can improve access, convenience, and coordination in integrated behavioral health and primary care. It does not solve the workflow half. Without a defined handoff, programs see missed dose changes, duplicate or conflicting prescriptions, follow-up nobody owns, and overdose risk that never reaches the treating physician.

What follows is a program-level workflow guide — what information moves, how prescribing is shared, and how consent works under HIPAA and 42 CFR Part 2 — not a clinical primer.

What information should move between the psychiatrist and primary physician

Coordination fails when each side assumes the other has the chart. Define the shared data set before the first virtual visit.

At intake, the referring practice sends: substance use history, current medications and doses, allergies, prior treatment episodes and outcomes, overdose history, co-occurring psychiatric needs, and medical comorbidities that bear on prescribing.

After the evaluation, the psychiatrist returns: the diagnosis, the treatment plan, any medication started or changed — including buprenorphine or naltrexone initiation — monitoring requirements, and the date of the next follow-up.

The primary physician sends back: the active problem list, recent labs, chronic medications, known contraindications, and any medical change that alters psychiatric prescribing.

Agree in advance on what triggers a same-week message rather than a routine note: relapse risk, adverse effects, missed visits, pregnancy, hepatic or renal findings, or a new controlled medication from another prescriber.

Documentation standards matter as much as content. Both teams should see the same plan, in the same format, so no one duplicates a taper or writes a conflicting prescription.

How medication management works for buprenorphine, naltrexone, and other SUD medications

Medication assisted treatment or SUD

Medications for opioid use disorder — buprenorphine, naltrexone, or another agent matched to the clinical picture — are evidence-based treatments, per SAMHSA’s guidance on integrating substance use disorder services. The coordination question is not whether to prescribe, but who owns each decision.

In most shared-care arrangements, the remote psychiatrist retains initiation, dose adjustment, scheduled response review, and side-effect monitoring. The primary physician typically supports ordering and interpreting labs, managing comorbidities such as diabetes, hepatitis C, or chronic pain, and providing local in-person follow-up when a virtual visit isn’t sufficient.

Reconciliation belongs in the intake assessment and again at every dose change: sedatives, opioid analgesics, antidepressants, sleep aids, and gabapentinoids all change the safety calculus. Name the trigger list that requires same-day contact with the primary physician — excess sedation, unresolved withdrawal, missed doses, suspected diversion, or return to use.

Finally, put the operational rules in writing: refill boundaries and who authorizes them, monitoring cadence including drug screening and visit frequency, and which clinician answers urgent medication questions after hours.

Consent, privacy, and release-of-information workflows for shared care

Nothing clinically useful moves between a remote psychiatrist and a primary physician until the paperwork is right. Under HIPAA, treatment-related exchange between providers is generally permitted; records from federally assisted substance use disorder programs carry the added protections of 42 CFR Part 2, which historically required patient consent before disclosure and restricts redisclosure downstream. The practical consequence: a signed release of information should be in hand before any routine exchange of addiction-related detail — buprenorphine or naltrexone dosing, toxicology results, relapse risk — not requested after the primary physician calls.

A workable intake sequence for programs running substance abuse telepsychiatry:

  1. Capture consent during the intake assessment, while the patient is already on camera with a clinician.
  2. Name the recipient specifically — the individual physician or practice, not “the patient’s doctors.”
  3. Specify what may be shared: diagnosis, medication and dose, appointment adherence, lab results.
  4. Set an expiration or review date, and log each disclosure in the chart.

Keep disclosures to the minimum necessary, and document medical emergencies handled under exception rather than treating them as precedent. The HHS guidance on integrating telehealth into substance use disorder treatment notes virtual care can improve privacy and reduce stigma — an advantage programs forfeit when consent handling looks careless.

A practical shared-care workflow for behavioral health program directors

Start by writing the sequence down. A referral arrives from the primary physician or an internal screening, scheduling books the visit, and the psychiatrist completes an intake assessment. Consent under HIPAA and 42 CFR Part 2 is collected before the first note leaves the program — not after. The initial psychiatric evaluation, including diagnosis, medication plan, and monitoring requirements, goes back to the referring physician within a defined window.

Assign an owner to every step, not every role. Typically: clinic staff handle scheduling and lab follow-up; the psychiatrist owns medication reconciliation, dose changes, and refill authorization for buprenorphine or naltrexone; the primary care team flags comorbid conditions and adverse effects. Escalation for relapse or safety concerns needs a named contact and a response time, not a general inbox.

A three-message cadence covers most programs: intake summary, periodic treatment update, and change-of-status alerts. A remote medical director can audit that cadence across sites, keeping documentation consistent when substance abuse telepsychiatry coverage is spread thin across clinics, hospitals, and correctional settings.

FAQ: Common questions about coordinating addiction care with primary physicians

Who makes the first contact after intake? The prescribing psychiatrist or psychiatric nurse practitioner should, ideally within a few business days of the initial substance use evaluation. Sending the diagnosis, medication plan, and monitoring schedule before the primary physician’s next visit prevents duplicate prescribing.

What if the primary physician changes a medication? Any new prescription with sedative, cardiac, or hepatic implications — benzodiazepines, opioid analgesics after surgery — should trigger a direct note back to the psychiatrist so buprenorphine or naltrexone dosing and relapse risk can be reassessed before the change takes effect.

How often should updates be exchanged? For stable patients, a summary at each dose change plus a routine note every one to three months is workable. After a missed dose series, a positive toxicology result, or a hospitalization, updates should move to same-week contact.

Can this work alongside therapy and recovery support? Yes. SAMHSA’s guidance for physicians treats coordinated medication and psychosocial care as standard practice, and FasPsych’s materials describe coordination with primary care providers, therapists, and recovery programs as part of its substance abuse telepsychiatry work.

What about consent? Obtain written, specific release language covering both HIPAA and 42 CFR Part 2 before the first exchange, and document each disclosure.

To review how shared-care coordination would fit your program’s staffing and intake structure, contact FasPsych.

B2B Partnership Request